Olivier Rixe
Impact in
- Pulmonary and Respiratory Medicine top 0.2%
- Renal cell carcinoma treatment
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 56
- Cancer Treatment and Pharmacology 12
-
- Renal cell carcinoma treatment 24
- Lung Cancer Treatments and Mutations 7
- Co-authors
- Stéphane Marie. Oudard (7 shared papers)Paul W. Bycott (3 shared papers)Robert John Motzer (4 shared papers)Marc Dror Michaelson (2 shared papers)Ronald M. Bukowski (2 shared papers)Thomas E. Hutson (1 shared paper)Isan Chen (1 shared paper)Sindy T. Kim (1 shared paper)
- Journals
- Annals of Oncology (12 papers)Targeted Oncology (10 papers)European Journal of Cancer (9 papers)Journal of Clinical Oncology (8 papers)Clinical Cancer Research (7 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Olivier Rixe
152 papers receiving 11.5k citations
Olivier Rixe's Hit Papers
Peers
Comparison fields: 5 of 146
- Pulmonary and Respiratory Medicine 5.0k
- Oncology 3.8k
- Cancer Research 2.0k
- Biological Psychiatry 145
- Molecular Biology 4.0k
Countries citing papers authored by Olivier Rixe
This map shows the geographic impact of Olivier Rixe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Rixe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Rixe more than expected).
Fields of papers citing papers by Olivier Rixe
This network shows the impact of papers produced by Olivier Rixe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Rixe. The network helps show where Olivier Rixe may publish in the future.
Co-authors
The 25 scholars most cited alongside Olivier Rixe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 2007 | 4810 |
| 2 | 1996 | 532 | |
| 3 | 2007 | 376 | |
| 4 | 2007 | 375 | |
| 5 | 2008 | 210 | |
| 6 | 2003 | 207 | |
| 7 | 2008 | 199 | |
| 8 | 2005 | 195 | |
| 9 | 2010 | 187 | |
| 10 | 2006 | 181 | |
| 11 | 2005 | 167 | |
| 12 | 2011 | 161 | |
| 13 | 2007 | 157 | |
| 14 | 2018 | 148 | |
| 15 | 2007 | 144 | |
| 16 | 2002 | 133 | |
| 17 | 2010 | 131 | |
| 18 | 2014 | 131 | |
| 19 | 1993 | 124 | |
| 20 | 2007 | 123 |
About Olivier Rixe
Olivier Rixe is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Biological Psychiatry, having authored 159 papers that have together received 11.9k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Cancer Treatment and Pharmacology (12 papers), Virus-based gene therapy research (9 papers), Cancer therapeutics and mechanisms (8 papers), Immunotherapy and Immune Responses (8 papers), Tryptophan and brain disorders (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Renal and related cancers (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.0k citations), Oncology (3.8k citations), Cancer Research (2.0k citations), Biological Psychiatry (145 citations) and Molecular Biology (4.0k citations). Olivier Rixe has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Stéphane Marie. Oudard, Paul W. Bycott, Robert John Motzer, Marc Dror Michaelson, Ronald M. Bukowski, Thomas E. Hutson, Isan Chen, Sindy T. Kim, Charles M. Baum and Sylvie Négrier. Their work appears in journals such as Annals of Oncology, Targeted Oncology, European Journal of Cancer, Journal of Clinical Oncology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.